Allogene stock price

Author: gngq

August undefined, 2024

WebApr 13, 2024 · 13 analysts have issued 1 year price objectives for Allogene Therapeutics' shares. Their ALLO share price forecasts range from $6.00 to $31.00. On average, they … WebMar 30, 2024 · Allogene had $576.5 million of cash, cash equivalents and investments as of Dec 31, 2024, compared with $637.3 million as of Sep 30, 2024. 2024 Guidance Allogene anticipates operating expenses...

Allogene Therapeutics Inc. (NASDAQ: ALLO): Making Its Way Up The Stock ...

WebApr 6, 2024 · Allogene Therapeutics Inc lowest stock price was $4.72 and its highest was $17.49 in the past 12 months. What is Allogene Therapeutics Inc’s market cap? ... WebApr 12, 2024 · The average twelve-month price prediction for Allogene Therapeutics is $17.69 with a high price target of $31.00 and a low price target of $6.00. Do Wall Street … radio pooki taajuus jyväskylä

Allogene Therapeutics (Nasdaq:ALLO) - Stock Price, News

WebApr 13, 2024 · The company’s stock has been forecasted to trade at an average price of $16.65 over the course of the next 52 weeks, with a low of $6.00 and a high of $35.00. Based on these price targets, the low is -30.72% off current price, whereas the price has to move -662.53% to reach the yearly target high. WebMar 1, 2024 · Stock Information Stock Quote & Chart Historical Price Look Up Investment Calculator Corporate Governance Documents & Charters ESG Report Board of Directors … WebApr 14, 2024 · Get a technical analysis of Allogene Therapeutics Inc (ALLO) with the latest MACD of -0.37 and RSI of 29.49. Stay up-to-date on market trends with our expert analysis. ... (ALLO) stock price is $5.05 and Allogene Therapeutics Inc ’s (ALLO) 100-day simple moving average is 6.89, creating a Sell signal. radio pori yhteystiedot

Allogene Therapeutics Inc (ALLO) Stock Price, Trades & News

Allogene Therapeutics (ALLO) Price To Cash Flow - Zacks.com

WebMar 21, 2024 · Analysts have provided the following ratings for Allogene Therapeutics (NASDAQ:ALLO) within the last quarter: These 10 analysts have an average price target of $19.0 versus the current price... WebSOUTH SAN FRANCISCO, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that it will participate in four upcoming investor conferences. Canaccord Genuity - CG … cute jelly silicone phone caseWebApr 10, 2024 · Price Target. Based on short-term price targets offered by 15 analysts, the average price target for Allogene Therapeutics comes to $17.73. The forecasts range from a low of $6.00 to a high of $35.00. radio pooki äänestys

"WebApr 11, 2024 · Allogene Therapeutics Inc. (ALLO) is priced at $4.53 after the most recent trading session. Allogene Therapeutics Inc. had a pretty Dodgy run when it comes to the … " - Allogene stock price

Allogene stock price

2024-04-13 NDAQ:ALLO Press Release Allogene …

WebApr 12, 2024 · According to 27 analysts, the average rating for ALLO stock is "Buy." The 12-month stock price forecast is $18.06, which is an increase of 293.46% from the latest … WebStock Quote & Chart. NASDAQ GS: ALLO. $4.94. Mar 31, 2024 4:00 PM EDT. Change. -0.03 (-0.60%) Volume. 1,940,970. Today's Open.

Did you know?

WebAllogene Therapeutics Inc Follow Share $4.89 After Hours: $4.89 (0.00%) 0.00 Closed: Apr 6, 4:56:21 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Beyond Meat … WebWall Street Stock Market & Finance report, prediction for the future: You'll find the Allogene Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Allogene Therapeutics's ALLO shares and potentially its market environment have been in bearish cycle last 12 months (if exists).

WebDec 8, 2024 · Allogene Therapeutics (ALLO) closed the last trading session at $9.03, gaining 3.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets... WebOn average, Wall Street analysts predict. that Allogene Therapeutics's share price could reach $18.64 by Apr 4, 2024. The average Allogene Therapeutics stock price prediction forecasts a potential upside of 281.1% from the current ALLO share price of $4.89 .

WebView the latest Allogene Therapeutics Inc. (ALLO) stock price, news, historical charts, analyst ratings and financial information from WSJ. ALLO Allogene Therapeutics Inc. … WebApr 12, 2024 · ALLO Stock Overview. Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T …

WebAllogene Therapeutics, Inc. (ALLO) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 4.8900 -0.0500 (-1.01%) At close: 04:00PM EDT 4.8900 0.00 …

WebApr 10, 2024 · ALLOGENE THERAPEUTICS, INC. (NASDAQ:ALLO) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share ALLOGENE … radio pookin lista äänestysWebGet Allogene Therapeutics Inc (ALLO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. cute iphone 13 mini casesWebMar 24, 2024 · Allogene Therapeutics, Inc. ( NASDAQ:ALLO – Get Rating )’s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $5.20 and last traded at $5.28, with a volume of 268912 shares changing hands. The stock had previously closed at $5.36. Analysts Set New Price Targets radio pooki taajuus lappeenrantaWebStock analysis for Allogene Therapeutics Inc (ALLO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. cute iphone 14 pro max casesWebAllogene is developing allogeneic chimeric antigen receptor T cell (AlloCAR T™) products to find the next immunologic breakthrough in cancer. That’s how we’re leading today, creating tomorrow. LEARN ABOUT AlloCAR T™ LEADING THE FUTURE OF CELL THERAPY WITH OUR AlloCAR T™ PLATFORM INNOVATION Multiplex gene … radio puhe toimittajatWebAllogene, launched in 2024, quickly established a leadership position in allogeneic cell therapy. It currently has over 320 employees and was recently named a 2024 Best Place to Work by BioSpace. “Allogene’s people are vital to the Company’s mission to develop the first AlloCAR T products for patients with cancer,” said Susan Lundeen ... cute kitten clipartWebApr 7, 2024 · See the latest Allogene Therapeutics Inc stock price (NASDAQ:ALLO), related news, valuation, dividends and more to help you make your investing decisions. cute kid valentine quotes